FDA
approval
· 2012-06-26
FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
Summary
FDA approved an original application for a generic product combining clindamycin phosphate and benzoyl peroxide for topical treatment of acne vulgaris.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN, BENZOYL PEROXIDE)